Revance Therapeutics (RVNC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RVNC | NAUT | INZY | ||
| Company | Revance Therapeutics | Nautilus Biotechnology Inc | Inozyme Pharma Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.63 | 2.26 | 4.48 | ||
| High | 2.74 | 2.36 | 4.50 | ||
| Low | 2.59 | 2.20 | 4.42 | ||
| Last | 2.67 | 2.30 | 4.49 | ||
| Change | -0.01 | +0.03 | unch | ||
| % Change | -0.37% | +1.32% | unch | ||
| Volume | 1,097,900 | 64,900 | 154,100 | ||
| 20-Day Average Volume | 1,651,120 | 81,595 | 355,865 | ||
| Previous Close | 2.68 | 2.27 | 4.49 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.70 | 2.45 | 4.57 | ||
| 20-Day Raw Stochastic | 40.66% | 15.94% | 30.12% | ||
| 20-Day Relative Strength | 43.51% | 42.30% | 45.66% | ||
| Weighted Alpha | -84.49 | -34.53 | -14.45 | ||
| Today's Opinion | 100% Sell | 100% Sell | 88% Sell | ||
| Previous Opinion | 100% Sell | 100% Sell | 88% Sell | ||
| Last Month's Opinion | 100% Sell | 64% Sell | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.49% since 06/27/24 | +0.88% since 06/27/24 | -0.66% since 06/27/24 | ||
| Low | 2.39 on 07/02/24 | 2.20 on 07/05/24 | 4.32 on 07/02/24 | ||
| High | 2.75 on 07/01/24 | 2.38 on 06/28/24 | 4.66 on 07/02/24 | ||
| 1-Month | |||||
| %Chg | -11.88% since 06/05/24 | -10.85% since 06/05/24 | -7.42% since 06/05/24 | ||
| Low | 2.30 on 06/26/24 | 2.19 on 06/24/24 | 4.24 on 06/18/24 | ||
| High | 3.21 on 06/12/24 | 2.88 on 06/12/24 | 5.07 on 06/13/24 | ||
| 3-Month | |||||
| %Chg | -39.46% since 04/05/24 | -13.86% since 04/05/24 | -29.95% since 04/05/24 | ||
| Low | 2.30 on 06/26/24 | 2.19 on 06/24/24 | 4.18 on 04/25/24 | ||
| High | 4.94 on 04/09/24 | 3.00 on 04/30/24 | 7.01 on 04/08/24 | ||
| 6-Month | |||||
| %Chg | -68.02% since 01/05/24 | -24.59% since 01/05/24 | +5.65% since 01/05/24 | ||
| Low | 2.30 on 06/26/24 | 2.19 on 06/24/24 | 4.03 on 01/17/24 | ||
| High | 7.59 on 01/09/24 | 3.25 on 01/09/24 | 7.80 on 04/01/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 279,923 | 284,352 | 277,733 | ||
| Shares Outstanding, K | 104,449 | 125,265 | 61,856 | ||
| Annual Sales | 234,040,000 | 0 | 0 | ||
| Annual Net Income | -323,990,000 | -63,680,000 | -71,170,000 | ||
| Last Quarter Sales | 51,940,000 | 0 | 0 | ||
| Last Quarter Net Income | -53,150,000 | -18,730,000 | -23,350,000 | ||
| 60-Month Beta | 0.98 | 1.20 | 1.53 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.54 on 05/09/24 | -0.15 on 04/30/24 | -0.38 on 05/07/24 | ||
| Latest Earnings Date | 08/13/24 | 08/07/24 | 08/13/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||